vs

Side-by-side financial comparison of SOLESENCE, INC. (SLSN) and UNIVERSAL HEALTH REALTY INCOME TRUST (UHT). Click either name above to swap in a different company.

UNIVERSAL HEALTH REALTY INCOME TRUST is the larger business by last-quarter revenue ($24.5M vs $12.5M, roughly 2.0× SOLESENCE, INC.). UNIVERSAL HEALTH REALTY INCOME TRUST runs the higher net margin — 17.7% vs 1.3%, a 16.4% gap on every dollar of revenue. On growth, SOLESENCE, INC. posted the faster year-over-year revenue change (-0.7% vs -0.7%). Over the past eight quarters, SOLESENCE, INC.'s revenue compounded faster (12.5% CAGR vs -1.3%).

Universal Health Services, Inc. (UHS) is an American Fortune 500 company that provides hospital and healthcare services, based in King of Prussia, Pennsylvania. In 2024, UHS reported total revenues of $15.8 billion.

SLSN vs UHT — Head-to-Head

Bigger by revenue
UHT
UHT
2.0× larger
UHT
$24.5M
$12.5M
SLSN
Growing faster (revenue YoY)
SLSN
SLSN
+0.0% gap
SLSN
-0.7%
-0.7%
UHT
Higher net margin
UHT
UHT
16.4% more per $
UHT
17.7%
1.3%
SLSN
Faster 2-yr revenue CAGR
SLSN
SLSN
Annualised
SLSN
12.5%
-1.3%
UHT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SLSN
SLSN
UHT
UHT
Revenue
$12.5M
$24.5M
Net Profit
$163.0K
$4.3M
Gross Margin
27.5%
Operating Margin
1.5%
34.7%
Net Margin
1.3%
17.7%
Revenue YoY
-0.7%
-0.7%
Net Profit YoY
129.2%
-7.2%
EPS (diluted)
$0.00
$0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SLSN
SLSN
UHT
UHT
Q4 25
$12.5M
$24.5M
Q3 25
$14.6M
$25.3M
Q2 25
$20.4M
$24.9M
Q1 25
$14.6M
$24.5M
Q4 24
$12.6M
$24.6M
Q3 24
$16.9M
$24.5M
Q2 24
$13.0M
$24.7M
Q1 24
$9.9M
$25.1M
Net Profit
SLSN
SLSN
UHT
UHT
Q4 25
$163.0K
$4.3M
Q3 25
$-1.1M
$4.0M
Q2 25
$2.7M
$4.5M
Q1 25
$80.0K
$4.8M
Q4 24
$-559.0K
$4.7M
Q3 24
$3.0M
$4.0M
Q2 24
$856.0K
$5.3M
Q1 24
$893.0K
$5.3M
Gross Margin
SLSN
SLSN
UHT
UHT
Q4 25
27.5%
Q3 25
23.1%
Q2 25
28.9%
Q1 25
23.1%
Q4 24
22.0%
Q3 24
36.2%
Q2 24
28.7%
Q1 24
36.3%
Operating Margin
SLSN
SLSN
UHT
UHT
Q4 25
1.5%
34.7%
Q3 25
-5.4%
33.2%
Q2 25
9.4%
35.6%
Q1 25
1.8%
36.8%
Q4 24
-1.8%
37.6%
Q3 24
19.0%
34.7%
Q2 24
8.0%
38.7%
Q1 24
11.3%
37.6%
Net Margin
SLSN
SLSN
UHT
UHT
Q4 25
1.3%
17.7%
Q3 25
-7.7%
15.9%
Q2 25
13.1%
18.1%
Q1 25
0.5%
19.5%
Q4 24
-4.4%
18.9%
Q3 24
18.1%
16.3%
Q2 24
6.6%
21.3%
Q1 24
9.0%
21.1%
EPS (diluted)
SLSN
SLSN
UHT
UHT
Q4 25
$0.00
$0.32
Q3 25
$-0.02
$0.29
Q2 25
$0.04
$0.32
Q1 25
$0.00
$0.34
Q4 24
$0.00
$0.34
Q3 24
$0.04
$0.29
Q2 24
$0.01
$0.38
Q1 24
$0.02
$0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SLSN
SLSN
UHT
UHT
Cash + ST InvestmentsLiquidity on hand
$1.3M
$6.7M
Total DebtLower is stronger
$374.8M
Stockholders' EquityBook value
$17.6M
$152.4M
Total Assets
$50.1M
$564.9M
Debt / EquityLower = less leverage
2.46×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SLSN
SLSN
UHT
UHT
Q4 25
$1.3M
$6.7M
Q3 25
$429.0K
$6.9M
Q2 25
$4.1M
$6.6M
Q1 25
$1.8M
$7.0M
Q4 24
$1.4M
$7.1M
Q3 24
$2.9M
$6.4M
Q2 24
$2.4M
$5.6M
Q1 24
$2.0M
$7.7M
Total Debt
SLSN
SLSN
UHT
UHT
Q4 25
$374.8M
Q3 25
Q2 25
Q1 25
Q4 24
$368.4M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
SLSN
SLSN
UHT
UHT
Q4 25
$17.6M
$152.4M
Q3 25
$17.2M
$158.6M
Q2 25
$18.2M
$165.2M
Q1 25
$15.2M
$172.2M
Q4 24
$14.9M
$179.5M
Q3 24
$15.2M
$181.6M
Q2 24
$11.9M
$190.7M
Q1 24
$5.0M
$196.5M
Total Assets
SLSN
SLSN
UHT
UHT
Q4 25
$50.1M
$564.9M
Q3 25
$54.0M
$568.0M
Q2 25
$60.0M
$573.0M
Q1 25
$57.0M
$573.5M
Q4 24
$50.0M
$580.9M
Q3 24
$48.0M
$584.3M
Q2 24
$40.8M
$586.6M
Q1 24
$38.5M
$596.2M
Debt / Equity
SLSN
SLSN
UHT
UHT
Q4 25
2.46×
Q3 25
Q2 25
Q1 25
Q4 24
2.05×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SLSN
SLSN
UHT
UHT
Operating Cash FlowLast quarter
$1.8M
$49.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
11.16×
11.35×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SLSN
SLSN
UHT
UHT
Q4 25
$1.8M
$49.1M
Q3 25
$-2.5M
$10.2M
Q2 25
$-654.0K
$13.7M
Q1 25
$-7.2M
$11.6M
Q4 24
$2.2M
$46.9M
Q3 24
$4.2M
$9.9M
Q2 24
$-565.0K
$12.1M
Q1 24
$-3.9M
$11.7M
Free Cash Flow
SLSN
SLSN
UHT
UHT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$-404.0K
Q3 24
$2.8M
Q2 24
$-1.0M
Q1 24
$-3.9M
FCF Margin
SLSN
SLSN
UHT
UHT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-3.2%
Q3 24
16.6%
Q2 24
-8.0%
Q1 24
-39.9%
Capex Intensity
SLSN
SLSN
UHT
UHT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
20.6%
Q3 24
8.3%
Q2 24
3.7%
Q1 24
0.9%
Cash Conversion
SLSN
SLSN
UHT
UHT
Q4 25
11.16×
11.35×
Q3 25
2.54×
Q2 25
-0.25×
3.05×
Q1 25
-90.26×
2.43×
Q4 24
10.06×
Q3 24
1.38×
2.48×
Q2 24
-0.66×
2.30×
Q1 24
-4.32×
2.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SLSN
SLSN

Segment breakdown not available.

UHT
UHT

Reportable Segment Aggregation Before Other Operating Segment$23.1M94%
Equity Method Investment Nonconsolidated Investee Or Group Of Investees$2.3M9%

Related Comparisons